Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8243
Evaluation of VM-26 and Ifosfamide in Refractory Adult Acute Lymphocytic Leukemia
Activated
02-18-1983
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8360
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8273
Evaluation of Cis-Platinum and DTIC in Disseminated Melanoma
Activated
01-31-1983
Closed
07-15-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8239
Evaluation of Spirogermanium (NSC-192965) in Central Nervous System Tumors
Activated
01-31-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8245
Combination Chemotherapy of Unfavorable Histology Non-Hodgkin's Lymphoma with CHOP and CVB (Alternating)
Activated
12-23-1982
Closed
03-16-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8241
Treatment of Advanced Non-Small Cell Lung Cancer: PVp Versus PVpM Versus PVe Versus PVeMI Versus FOMi/CAP
Research Committee(s)
Lung Cancer
Activated
12-23-1982
Closed
11-01-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8203/04
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8208
Trial of Chlorozotocin and 5-FU in Metastatic Islet Cell Carcinoma
Activated
12-01-1982
Closed
02-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8232
Treatment of Limited Small Cell Lung Cancer with VP-16/ Cis-Platinum, Alternating with Vincristine/Adriamycin/Cyclophosphamide and Radiation Therapy Versus Concurrent VP-16/Vincristine/Adriamycin/Cyclophosphamide and Radiation Therapy
Research Committee(s)
Lung Cancer
Activated
12-01-1982
Closed
10-03-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8216/38
Comparison of BCG Immunotherapy and Adriamycin for Superficial Bladder Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-01-1982
Closed
01-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8044
Evaluation of AZQ in Pancreatic Carcinoma TEMPORARILY CLOSED: 8/17/84
Activated
10-29-1982
Closed
03-22-1985
Closed
Phase
Accrual
81%
Published
SWOG Clinical Trial Number
SWOG-8221 (INT-0007)
Treatment of Advanced Bladder Cancer with Preoperative Irradiation and Radical Cystectomy versus Radical Cystectomy Alone
Research Committee(s)
Genitourinary Cancer
Activated
10-29-1982
Closed
11-15-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8229/30
Combined Modality Therapy for Multiple Myeloma, VMCP-VBAP for Remission Induction Therapy: VMCP vs. Sequential Half-Body Radiotherapy + Vincristine-Prednisone for Maintenance or Consolidation. Evaluation of Half-body Radiotherapy + Vincristine-Prednisone for patients Who Fail to Achieve Remission Status with Chemotherapy Alone
Research Committee(s)
Myeloma
Activated
10-15-1982
Closed
11-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8231
Chemotherapy of Extragonadal Germinal Cell Neoplasms
Activated
09-29-1982
Closed
10-15-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8214
Evaluation of Bisantrene Hydrochloride in Advanced Sarcoma
Activated
09-17-1982
Closed
01-19-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8228
Correlation Between Progesterone Receptor and Response to Tamoxifen in Patients with Newly Diagnosed Metastatic Breast Cancer
Activated
09-17-1982
Closed
02-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8209
A Study of AZQ (aziridinylbenzoquinone) in Soft Tissue and Bony Sarcomas
Activated
08-25-1982
Closed
05-27-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8217
Evaluation of Spirogermanium (NSC-192965) in Adenocarcinoma of the Prostate
Activated
08-11-1982
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8269
Concurrent Chemo-Radiotherapy for Limited Small Cell Carcinoma of the Lung OPENED GROUPWIDE: 3/22/85
Activated
08-11-1982
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8218
Evaluation of Spirogermanium (NSC-192965) in Renal Cell Carcinoma
Activated
07-21-1982
Closed
10-18-1983